Funding

Two funding proposals

Michael R. Stallcup
By Michael R. Stallcup
Nov. 1, 2018

One of the main problems facing all biomedical researchers these days (new and old ones alike) is that there are simply too many scientists applying for too few dollars. Changing the number of scientists who apply for funding is difficult to address, and a huge increase in the budgets of federal funding agencies does not look likely in the near term. But there are some things that could be done to make more funding available to researchers within the current budgets of federal funding agencies.

Currently, federal agencies will allow principal investigators to pay for up to 95 percent of their salaries from grants. If the percentage of salary that could be obtained from federal grants and contracts were to be limited to, say, 50 percent, this would make more funds available for the actual research and would, in effect, make universities and other research institutions take more responsibility for the salaries of their employees. A gradual implementation of such a policy over several years would allow the research institutions to make adjustments and avoid the adverse impact of a fast transition.

Another problem more specific to researchers in biochemistry and molecular biology is the difficulty in getting funding for basic research that has no obvious translational potential in the near term. I think this problem can be solved only by creation of new National Institutes of Health study sections with a mandate to review basic research. Currently, much of the basic research is crowded into a few study sections or sent to study sections that place a premium on translation.

Michael R. Stallcup
Michael R. Stallcup

Michael R. Stallcup is a professor of biochemistry and molecular medicine at the University of Southern California.
 

Join the ASBMB Today mailing list

Sign up to get updates on articles, interviews and events.

Latest in Policy

Policy highlights or most popular articles

ASBMB responds to proposal for new health research agency
Blotter

ASBMB responds to proposal for new health research agency

July 27, 2021

Society recommends keeping funding for ARPA-H separate from that of other agencies and developing a unique strategic plan.

Why is the FDA funded in part by the companies it regulates?
Funding

Why is the FDA funded in part by the companies it regulates?

July 4, 2021

The U.S. Food and Drug Administration receives almost half its funding from companies it regulates, such as drug and medical device makers. Is this something you should be concerned about?

ASBMB calls for changes to Title IX policy
Blotter

ASBMB calls for changes to Title IX policy

June 16, 2021

Society urges Department of Education to revise rule created by Trump administration.

Rethinking the NIH review system
Reimagining

Rethinking the NIH review system

June 10, 2021

Proposals for change include a tiered grant funding system, tweaks to scoring and criteria, internal reviews and a continuous submission system.

Analysis: Mounting pressure on China about coronavirus ‘lab leak’ could backfire
News

Analysis: Mounting pressure on China about coronavirus ‘lab leak’ could backfire

June 9, 2021

Where the coronavirus originated remains a mystery, and the Chinese are bucking demands to let investigators see more.

Two years of the DOJ’s China Initiative
Blotter

Two years of the DOJ’s China Initiative

April 14, 2021

Despite the agency’s intense scrutiny of scientists at academic institutions, few have been convicted, and none has been accused of economic espionage.